Literature DB >> 3128915

The juxtaglomerular apparatus in Bartter's syndrome and related tubulopathies. An immunocytochemical and electron microscopic study.

R Taugner1, R Waldherr, H W Seyberth, E G Erdös, J Menard, D Schneider.   

Abstract

A comparative immunocytochemical and electron microscopic study was performed on renal biopsies from two children with classical Bartter's syndrome (BS) and three children with a recently described variant, the so-called hyperprostaglandin E-syndrome (HES). Compared to age-matched controls, kidney specimens from patients with BS and HES disclosed a marked hypertrophy and hyperplasia of the juxtaglomerular apparatus (JGA). In addition, in HES focal tubular and interstitial calcifications accompanied by interstitial fibrosis and tubular atrophy were noted. On immunocytochemistry, chronic stimulation of the JGA in BS and HES was characterized by an increase in the number of renin-positive cells, particularly in the media of afferent arterioles, but also in efferent arterioles and in the glomerular stalk. The length of the renin-positive portion of the preglomerular arterioles was significantly increased when compared to controls (100 +/- 32 vs. 49 +/- 17 microns; p less than 0.001). In addition, the immunoreactivity of individual renin-positive cells was markedly enhanced. On electron microscopy, "hypertrophy" of the RER and of Golgi complexes with paracrystalline deposits in dilated RER cisterns and protogranules indicated an increased renin synthesis. Renin could be identified in mature secretory granules as well as protogranules by immune electron microscopy. Angiotensinogen was present in hypertrophied epithelial cells of Bowman's capsule. Converting-enzyme reactivity was observed in controls as well as in BS and HES in the brush border of the proximal tubule. In contrast to previous reports, Angiotensin II was completely negative in control as well as in diseased kidneys. We conclude from our results that both BS and HES are characterized by a marked activation of the JGA and severe stimulation of the renin-angiotensin system. Since activation of this system, however, leads--independently of the primary stimulus--to qualitatively very similar morphological reactions, these results do not implicate a common pathogenetic mechanism to both conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128915     DOI: 10.1007/bf00750580

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  53 in total

1.  Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.

Authors:  F C BARTTER; P PRONOVE; J R GILL; R C MACCARDLE
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

2.  The development and ultrastructure of the juxtaglomerular cell granule.

Authors:  L Barajas
Journal:  J Ultrastruct Res       Date:  1966-06

3.  The fate of prorenin during granulopoiesis in epithelioid cells. Immunocytochemical experiments with antisera against renin and different portions of the renin prosegment.

Authors:  R Taugner; S J Kim; K Murakami; R Waldherr
Journal:  Histochemistry       Date:  1987

4.  The structure of the juxtaglomerular apparatus in Addison's disease, Bartter's syndrome, and in Conn's syndrome: a comparative, morphometric, light microscopic study on serial secions.

Authors:  J A Christensen; H Bader; A Bohle; D S Meyer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-05-03

5.  The pathogenetic spectrum of Bartter's syndrome.

Authors:  J H Stein
Journal:  Kidney Int       Date:  1985-07       Impact factor: 10.612

6.  Coexistence of renin and angiotensin II in epitheloid cell secretory granules of rat kidney.

Authors:  R Taugner; E Mannek; R Nobiling; C P Bührle; E Hackenthal; D Ganten; T Inagami; H Schröder
Journal:  Histochemistry       Date:  1984

7.  Renin storage and cell differentiation in juxtaglomerular cell tumors: an immunohistochemical and ultrastructural study of three cases.

Authors:  J P Camilleri; N Hinglais; P Bruneval; J Bariety; V Tricottet; M Rouchon; R Mancilla-Jimenez; P Corvol; J Menard
Journal:  Hum Pathol       Date:  1984-11       Impact factor: 3.466

8.  Malignant hypertension due to a renin-secreting renal cell carcinoma--an ultrastructural and immunocytochemical study.

Authors:  G B Lindop; B Leckie; C G Winearls
Journal:  Histopathology       Date:  1986-10       Impact factor: 5.087

9.  Angiotensin II in epitheloid (renin containing) cells of rat kidney.

Authors:  R Taugner; E Hackenthal
Journal:  Histochemistry       Date:  1981

10.  Appearance of dense granules in the rough endoplasmic reticulum of the juxtaglomerular cells in mice administered with captopril.

Authors:  M Kaneta; K Abe; T Ito
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

View more
  6 in total

1.  The presence of a juxtaglomerular apparatus in elasmobranch fish.

Authors:  E R Lacy; E Reale
Journal:  Anat Embryol (Berl)       Date:  1990

Review 2.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  How can you differentiate neonatal Bartter's syndrome from hyperprostaglandin (-uria) E2 syndrome?

Authors:  H W Seyberth
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

4.  Kidney Disease Associated With Anorexia Nervosa: A Case Series With Kidney Biopsies.

Authors:  Hirokazu Marumoto; Takaya Sasaki; Nobuo Tsuboi; Tatsuhiko Ito; Masahiro Ishikawa; Makoto Ogura; Masato Ikeda; Takashi Yokoo
Journal:  Kidney Med       Date:  2020-06-05

5.  Renin-positive granulated Goormaghtigh cells. Immunohistochemical and electron-microscopic studies on biopsies from patients with pseudo-Bartter syndrome.

Authors:  J A Christensen; A Bohle; E Mikeler; R Taugner
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

Review 6.  Prostanoids in paediatric kidney diseases.

Authors:  H W Seyberth; A Leonhardt; B Tönshoff; N Gordjani
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.